View Author
cancer patient breast study breast cancer tumor brca 1 chemotherapy mutation university department breast cancer risk association carrier genetic receptor table center opioid survival control stage fi rst-line chemotherapy analysis research response oncology factor cancer patients case patients hydromorphone tumor subtypes hospital institute subtype pain control effect group therapy parenteral hydromorphone status fatigue disease treatment side effects centre women signi ficantly result family parenteral signi sample estrogen flammatory analyses tumour risk factors genetics service 1.00 carcinoma pro-in flammatory cytokines metastatic breast cancer cytokine medicine oncol brca 1- breast cancer patients netherland metastatic adjuvant level 2-associated epidemiology allele case –case analyses 1/her breast cancer res rst-line stage 1
10 Most Recent Publications
|
The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling
(Article)
Vencken, P.M.L.H. Kriege, M. Seynaeve, C.M. Hooning, M. Menke-Pluymers, M.B.E. Heemskerk-Gerritsen, B.A.M. Doorn, L.C. van Collee, J.M. Jager, A. Montfort, C.A.G.M. van Burger, C.W. |
2013-03-01
|
|
Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids
(Article)
Oldenmenger, W.H. Lieverse, P.J. Janssen, P.J.J.M. Taal, W. Rijt, C.C.D. van der Jager, A. |
2011-08-23
|
|
Metaplastic breast carcinoma: Tumour histogenesis or dedifferentiation?
(Article)
Deurzen, C.H.M. van Lee, A.H.S. Gill, M.S. Menke-Pluijmers, M. Jager, A. Ellis, I.O. Rakha, E.A. |
2011-08-01
|
|
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
(Article)
Vencken, P.M.L.H. Kriege, M. Seynaeve, C.M. Hoogwerf, D. Beugelink, S. Burg, M.E.L. van der Hooning, M. Berns, P.M.J.J. Jager, A. Collée, J.M. Burger, C.W. |
2011-06-06
|
|
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
(Article)
Osorio, A. Milne, R.L. Konstantopoulou, I. Hogervorst, F.B.L. Verhoef, S. Dooren, M.F. van Jager, A. Ausems, M.G.E.M. Aalfs, C. Asperen, C.J. van Vreeswijk, M.P. Waisfisz, Q. Pallás-Alonso, C.R. Roozendaal, C.E.P. van Ligtenberg, M. Easton, D.F. Peock, S. Cook, M.S. Oliver, C.T. Frost, D. Curzon, B. Evans, D.G. Lalloo, F. Pita, G. Eeles, R. Izatt, L. Davidson, R. Adlard, J.W. Eccles, D. Ong, K.R. Douglas, F. Downing, S. Brewer, C. Walker, L. Peterlongo, P. Nevanlinna, H. Aittomäki, K. Couch, F.J. Fredericksen, Z. Lindor, N.M. Godwin, A.K. Isaacs, C. Caligo, M.A. Loman, N. Jernström, H. Teulé, A. Barbany-Bustinza, G. Liljegren, A. Ehrencrona, H. Stenmark-Askmalm, M. Feliubadaló, L. Manoukian, S. Peissel, B. Zaffaroni, D. Bonanni, B. Fortuzzi, S. Nathanson, K.L. Johannsson, O.T. Chenevix-Trench, G. Chen, X.C. Beesley, J. Spurdle, A.B. Sinilnikova, O. Healey, S. McGuffog, L. Antoniou, A.C. Brunet, J. Domchek, S.M. Radice, P. Benítez, J. Rebbeck, T.R. Lasa, A. |
2011-05-01
|
|
Associations of breast cancer risk factors with tumor subtypes: A pooled analysis from the breast cancer association consortium studies
(Article)
Yang, X.R. Chang-Claude, J. Fasching, P.A. Shen, C.-Y. Hsiung, C.-N. Wu, P.E. Yu, J.-C. Chen, S.-T. Hsu, G.-C. Haiman, C.A. Henderson, B.E. Le Marchand, L. Kolonel, L.N. Hein, R. Lindblom, A. Margolin, S. Jakubowska, A. Lubinski, J. Huzarski, T. Byrski, T. Górski, B. Gronwald, J. Hooning, M. Hollestelle, A. Spurdle, A.B. Ouweland, A.M.W. van den Jager, A. Kriege, M. Tilanus-Linthorst, M.M.A. Collee, J.M. Wang-Gohrke, S. Pylkäs, K. Jukkola-Vuorinen, A. Mononen, K. Grip, M. Blows, F. Hirvikoski, P. Winqvist, R. Mannermaa, A. Kosma, V.M. Kauppinen, J. Kataja, V. Auvinen, P. Soini, Y. Sironen, R. Bojesen, S.E. Driver, K. Dynnes Ørsted, D. Kaur-Knudsen, D. Flyger, H. Nordestgaard, B.G. Holland, H. Chenevix-Trench, G. Manoukian, S. Barile, M. Radice, P. Hankinson, S.E. Flesch-Janys, D. Hunter, D. Tamimi, R. Sangrajrang, S. Brennan, P. McKay, J. Odefrey, F. Gaborieau, V. Devilee, P. Huijts, P. Tollenaar, R. Heinz, J. Seynaeve, C.M. Dite, G.S. Apicella, C. Hopper, J. Hammet, F. Tsimiklis, H. Smith, L. Southey, M.C. Easton, D.F. Pharoah, P. Sinn, P. Sherman, M. García-Closas, M. Vrieling, A. Heikinen, T. Goode, E.L. Aittomäki, K. Heikkilä, P. Blomqvist, C. Lissowska, J. Peplonska, B. Chanock, S.J. Figueroa, J. Brinton, L.A. Hall, A.S. Czene, k. Couch, F.J. Humphreys, M.K. Darabi, H. Liu, J. Veer, L.J. van 't Leeuwen, F.E. van Andrulis, I.L. Glendon, G. Knight, J.A. Mulligan, A.M. O'Malley, F.P. Nevanlinna, H. Weerasooriya, N. John, E.M. Beckmann, M.W. Hartmann, A. Weihbrecht, S.B. Wachter, D.L. Jud, S.M. Loehberg, C.R. Baglietto, L. English, D.R. Milne, R.L. Giles, G.G. McLean, C.A. Severi, G. Lambrechts, D. Vandorpe, T. Weltens, C. Paridaens, R. Smeets, A. Neven, P. Wildiers, H. Gaudet, M.M. Wang, X. Olson, J.E. Cafourek, V. Fredericksen, Z. Kosel, M. Vachon, C. Cramp, H.E. Connley, D. Cross, S.S. Balasubramanian, S. Schmidt, M.K. Reed, M.W.R. Dörk, T. Bremer, M. Meyer, A. Karstens, J.H. Ay, A. Park-Simon, T.-W. Hillemanns, P. Arias Pérez, J.I. Rodríguez, P.M. Broeks, A. Zamora, P. Benitez, J. Ko, Y.D. Fischer, H.-P. Hamann, U. Pesch, B. Brüning, T. Justenhoven, C. Brauch, H. Eccles, D. Cox, A. Tapper, W. Gerty, S.M. Sawyer, E.J. Tomlinson, I.P. Jones, A. Kerin, M. Miller, N. McInerney, N. Anton-Culver, H. Ziogas, A. |
2011-02-02
|
|
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
(Article)
Antoniou, A.C. Wang, X. Ghoussaini, M. Caldes, T. Hoya, M. de La Singer, C.F. Fink-Retter, A. Greene, M.H. Mai, P.L. Loud, J.T. Guidugli, L. Lindor, N.M. Hansen, T.V.O. Barrowdale, D. Nielsen, F.C. Blanco, I. Lazaro, C. Garber, J. Ramus, S.J. Gayther, S.A. Phelan, C. Narod, S. Szabo, C. Benitez, J. Peock, S. Osorio, A. Nevanlinna, H. Heikkinen, T. Caligo, M.A. Beattie, M.S. Hamman, U. Godwin, A.K. Montagna, M. Casella, C. Neuhausen, S.L. Cook, M. Karlan, B.Y. Tung, N. Toland, A.E. Weitzel, J. Olopade, P. Simard, J. Soucy, P. Rubinstein, W.S. Arason, A. Rennert, G. Oliver, C. Martin, N.G. Montgomery, G.W. Chang-Claude, J. Flesch-Janys, D. Brauch, H. Severi, G. Baglietto, L. Cox, A. Cross, S.S. Miron, P. Frost, D. Gerty, S.M. Tapper, W. Yannoukakos, D. Fountzilas, G. Fasching, P.A. Beckmann, M.W. Dos Santos Silva, I. Peto, J. Lambrechts, D. Paridaens, R. Eccles, D. Rüdiger, T. Försti, A. Winqvist, R. Pylkäs, K. Diasio, R.B. Lee, A.M. Eckel-Passow, J. Vachon, C. Blows, F. Driver, K. Evans, D.G. Dunning, A.M. Pharaoh, P.D.P. Offit, K. Pankratz, V.S. Hakonarson, H. Chenevix-Trench, G. Easton, D.F. Couch, F.J. Eeles, R. Izatt, L. Fredericksen, Z. Chu, C. Douglas, F. Paterson, J. Stoppa-Lyonnet, D. Houdayer, C. Mazoyer, S. Giraud, S. Lassett, C. Remenieras, A. Caron, O. McGuffog, L. Hardouin, A. Berthet, P. Hogervorst, F.B.L. Rookus, M.A. Jager, A. Ouweland, A.M.W. van den Hoogerbrugge, N. Luijt, R.B. van der Meijers-Heijboer, H. G'mez García, E.B. Tarrell, R. Devilee, P. Vreeswijk, M.P. Lubinski, J. Jakubowska, A. Gronwald, J. Huzarski, T. Byrski, T. G'rski, B. Cybulski, C. Spurdle, A.B. Sinilnikova, O. Holland, H. Goldgar, D. John, E.M. Hopper, J. Southey, M.C. Buys, S.S. Daly, M.B. Terry, M-B. Schmutzler, R.K. Wappenschmidt, B. Healey, S. Engel, C. Meindl, A. Preisler-Adams, S. Arnold, N. Niederacher, D. Sutter, C. Domchek, S.M. Nathanson, K.L. Rebbeck, T.R. Blum, J.L. Morrison, J. Piedmonte, M. Rodriguez, G.C. Wakeley, K. Boggess, J.F. Basil, J. Blank, S.V. Friedman, E. Kaufman, B. Laitman, Y. Milgrom, R. kartsonaki, C. Andrulis, I.L. Glendon, G. Ozcelik, H. Kirchhoff, T. Vijai, J. Gaudet, M.M. Altshuler, D. Guiducci, C. Loman, N. Harbst, K. Lesnick, T. Rantala, J. Ehrencona, H. Gerdes, A-M. Thomassen, M. Sunde, L. Peterlongo, P. Manoukian, S. Bonanni, B. Viel, A. Radice, P. |
2010-10-01
|
|
Chemotherapy: Adjuvant chemotherapy in older patients with breast cancer
(Article)
Jager, A. Verweij, J. Sleijfer, S. |
2009-10-14
|
|
Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers
(Article)
Kriege, M. Seynaeve, C.M. Ouweland, A.M.W. van den Geel, B.N. van Hooning, M. Brekelmans, C.T. Klijn, J.G.M. Meijers-Heijboer, H. Collee, J.M. Menke-Pluymers, M.B.E. Bartels, C.C.M. Tilanus-Linthorst, M.M.A. Blom, J. Huijskens, E. Jager, A. |
2009-08-10
|
|
The pathogenesis of cancer related fatigue: Could increased activity of pro-inflammatory cytokines be the common denominator?
(Article)
Jager, A. Sleijfer, S. Rijt, C.C.D. van der |
2008-01-01
|
